Literature DB >> 20373900

Effect of ZnCl2 and chelation of zinc ions by N,N-diethyldithiocarbamate (DEDTC) on the ERG b-wave amplitude from the isolated superfused vertebrate retina.

Siarhei A Siapich1, Heiko Wrubel, Walid Albanna, Maged Alnawaiseh, J Hescheler, Marco Weiergräber, Matthias Lüke, T Schneider.   

Abstract

PURPOSE: NiCl(2) (15 microM) enhances the ERG b-wave amplitude of vertebrate retina, up to 1.5-fold by blocking E/R-type voltage-gated Ca(2+) channels, which is mediated by blocking the release of GABA onto ionotropic GABA-A and GABA-C receptors. In vivo, it is likely that zinc, rather than nickel ions, may be involved in the modulation of retinal signalling. Therefore, we tested the effect of both, ZnCl(2) (10 to 500 microM) and DEDTC (100 to 500 microM), which chelates zinc ions for the capacity to influence the ERG b-wave amplitude.
METHODS: Transretinal potentials from the isolated bovine retina were recorded as electroretinograms and Ca(2+) inward currents by patch-clamp recordings of stably Ca(v)2.3 transfected HEK-293 cells, yielding an IC(50) value of 5.3 microM for ZnCl(2).
RESULTS: ZnCl(2) (10-15 microM) increased the b-wave amplitude by 1.52-fold +/- 0.12 (n = 6 retinas), which was partially reversible upon washout. The same 1.5-fold stimulation of the b-wave amplitude was reported recently for 15 microM NiCl(2). The superfusion of isolated retinas by DEDTC (100 microM) caused a transient decrease of the ERG b-wave amplitude (0.75-fold +/- 0.06; n = 4), suggesting that the co-secretion of Zn(2+) ions may occur under scotopic conditions.
CONCLUSION: The stimulatory effect of ZnCl(2) on the ERG b-wave amplitude resembles the stimulatory effect of NiCl(2) and may be mediated rather by the NiCl(2)-sensitive, Ca(v)2.3 E-/R-type voltage-gated Ca(2+) channels than by NiCl(2)-sensitive T-type channels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373900     DOI: 10.3109/02713680903509410

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Administration of Zinc Chelators Improves Survival of Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with Caspofungin.

Authors:  Paris Laskaris; Ahmad Atrouni; José Antonio Calera; Christophe d'Enfert; Hélène Munier-Lehmann; Jean-Marc Cavaillon; Jean-Paul Latgé; Oumaïma Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction.

Authors:  Siarhei A Siapich; Isha Akhtar; Jürgen Hescheler; Toni Schneider; Matthias Lüke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-25       Impact factor: 3.117

3.  Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.

Authors:  Maged Alnawaiseh; Walid Albanna; Chien-Chang Chen; Kevin P Campbell; Jürgen Hescheler; Matthias Lüke; Toni Schneider
Journal:  Acta Ophthalmol       Date:  2011-08-23       Impact factor: 3.761

4.  Evaluation of micro Electroretinograms Recorded with Multiple Electrode Array to Assess Focal Retinal Function.

Authors:  Momo Fujii; Genshiro A Sunagawa; Mineo Kondo; Masayo Takahashi; Michiko Mandai
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

Review 5.  Cav2.3 R-type calcium channels: from its discovery to pathogenic de novo CACNA1E variants: a historical perspective.

Authors:  T Schneider; F Neumaier; J Hescheler; S Alpdogan
Journal:  Pflugers Arch       Date:  2020-06-11       Impact factor: 3.657

6.  How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?

Authors:  Toni Schneider; Maxine Dibué; Jürgen Hescheler
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27

7.  Submicromolar copper (II) ions stimulate transretinal signaling in the isolated retina from wild type but not from Cav2.3-deficient mice.

Authors:  Jan Niklas Lüke; Felix Neumaier; Serdar Alpdogan; Jürgen Hescheler; Toni Schneider; Walid Albanna; Isha Akhtar-Schäfer
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.